Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
01/2003
01/15/2003EP1274692A1 Quinazoline compounds
01/15/2003EP1274691A1 2-guanidino-4-arylchinazolines as nhe-3 inhibitors
01/15/2003EP1274690A1 2-alkoxy-5-methoxypyrimidines or their tautomeric forms and methods for producing the same
01/15/2003EP1274683A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides
01/15/2003EP1274678A1 Novel alpha-sulfin- and alpha-sulfonamido acid amides
01/15/2003EP0983321B1 Fiber-reactive disazo dyestuffs
01/15/2003EP0929509B1 Liquid crystal alkenyl bicyclo 2.2.2]octanes and mixtures and devices containing such compounds
01/15/2003EP0862571B1 Herbicidal sulfonamides
01/15/2003EP0790989B1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
01/15/2003EP0591508B2 Electrooptical liquid crystal system
01/15/2003CN1391563A Therapeutic quinazoline derivatives
01/15/2003CN1391562A Quinazoline derivatives as pharmaceuticals
01/15/2003CN1391561A Quinazoline compounds and pharmaceutical compositions containing them
01/15/2003CN1391560A 喹唑啉衍生物 Quinazoline derivatives
01/15/2003CN1391469A Npyy5拮抗剂 Npyy5 antagonist
01/14/2003US6506908 From bicyclo(3.1.0)hexabe; decyclization; decarboxylation
01/14/2003US6506762 Certain alkylene diamine-substituted heterocycles
01/14/2003US6506749 7-oxo-pyridopyrimidines (I)
01/14/2003US6506744 Benzazepinone-derivatives
01/14/2003US6506517 Surface modified carbonaceous materials
01/09/2003WO2003002567A1 New pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections
01/09/2003WO2003002544A1 N-heterocyclic inhibitors of tnf-alpha expression
01/09/2003WO2003002543A1 Pyrimidinoxyalkylpiperazines and their therapeutic use
01/09/2003WO2003002532A1 Cyclic diamine compounds having fused-ring groups
01/09/2003WO2002087587A3 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
01/09/2003US20030009033 Substituted condensation products of N-benzyl-3-indenylacent amides with heterocyclic aldehydes for neoplasia
01/09/2003US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
01/09/2003US20030008900 Compounds and compositions for delivering active agents
01/09/2003US20030008888 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
01/09/2003US20030008884 Fungicidal phenyl (thio) urea and phenyl (thio) carbamate derivatives
01/09/2003US20030008883 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods
01/09/2003US20030008868 Compounds useful as anti-inflammatory agents
01/09/2003US20030006399 Electrooptical display
01/09/2003CA2451128A1 N-heterocyclic inhibitors of tnf-alpha expression
01/09/2003CA2451125A1 N-heterocyclic inhibitors of tnf-alpha expression
01/08/2003EP1273574A1 Process for the preparation of 4,6-dichloropyrimidine
01/08/2003EP1272900A2 High speed photothermographic materials containing tellurium compounds and methods of using same
01/08/2003EP1272478A1 Substituted phenyluracils
01/08/2003EP1272477A1 Pyrimidine compounds
01/08/2003EP1272469A1 Naphthalene derivatives and their pharmaceutical use
01/08/2003EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors
01/08/2003EP1272193A2 Synergistic methods and compositions for treating cancer
01/08/2003EP1272185A2 Use of quinazoline derivatives as angiogenesis inhibitors
01/08/2003EP1272168A2 Small organic molecule regulators of cell proliferation
01/08/2003EP1196500B1 Reactive dye compounds
01/08/2003CN1390208A Substituted phenyluracils and their use as herbicides
01/08/2003CN1390207A [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinyl amino] acetamide derivatives, process for producing the same, medicinal compositions the same and intermediate of these compounds
01/08/2003CN1390204A Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/08/2003CN1390196A Novel derivatives of dicarboxylic acid having pharmaceutical properties
01/08/2003CN1390128A Use of adatanserin for treating neurogenerative disorders
01/08/2003CN1389460A Potassium chlorobromo isocyanurate and its production process and application
01/08/2003CN1098254C Sulfonamides
01/07/2003US6504031 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents
01/07/2003US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection
01/07/2003CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease
01/07/2003CA2076690C Process for the production of 2-(methylthio)-disodium barbiturate
01/03/2003WO2003000666A1 5-ht receptor ligands and uses thereof
01/03/2003WO2003000665A1 Antibacterial uracil derivatives
01/03/2003WO2003000664A1 Uracil derivatives and the use thereof for treating bacterial diseases
01/03/2003WO2003000663A1 5-ht receptor ligands and uses thereof
01/03/2003WO2003000660A1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
01/03/2003WO2003000262A1 Vinyl phenyl derivatives as glk activators
01/03/2003WO2003000188A2 Novel quinazolines and uses thereof
01/03/2003WO2003000186A2 Novel phenylamino-pyrimidines and uses thereof
01/03/2003WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes
01/03/2003WO2002088101A3 Inhibitors of bace
01/03/2003WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
01/03/2003CA2455292A1 5-ht receptor ligands and uses thereof
01/03/2003CA2454538A1 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
01/03/2003CA2450491A1 5-ht receptor ligands and uses thereof
01/03/2003CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
01/02/2003US20030004347 Treatment for plant propagation material for parasiticides
01/02/2003US20030004339 Therapy for benign prostatic hyperplasia
01/02/2003US20030004174 Antiinflammatory agents, anticancer agents, antihistamines, central nervous system disorders
01/02/2003US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents
01/02/2003US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light
01/02/2003EP1270560A1 Hiv replication inhibiting pyrimidines
01/02/2003EP1270547A1 Novel phenylalanine derivative
01/02/2003EP1270017A1 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
01/02/2003EP1268480A1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
01/02/2003EP1268454A1 Succinoylamino heterocycles as inhibitors of a-beta protein production
01/02/2003EP1268448A1 Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases
01/02/2003EP1268447A2 Asymmetric synthesis of quinazolin-2-ones useful as hiv reverse transcriptase inhibitors
01/02/2003EP1268446A1 Method for producing asymmetrical 4,6-bis(aryloxy)pyrimidine derivatives
01/02/2003EP1268445A1 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
01/02/2003EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents
01/02/2003EP1268443A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use
01/02/2003EP1268442A2 Crystalline pharmaceutical
01/02/2003EP1268429A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
01/02/2003EP1268408A1 Arthropodicidal carboxanilides
01/02/2003EP1219614A9 Benzene sulfonamides as PDE-V inhibitors for the use against erectile dysfunction
01/02/2003EP0925286B1 Substituted pyrimidine derivatives and their pharmaceutical use
01/02/2003EP0821719B1 Liquid crystal compounds having a chiral fluorinated terminal portion
01/02/2003EP0630366B1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
01/01/2003CN1388123A Chloropyrimidine intermediate
01/01/2003CN1097592C Slfonic acid amide derivatives with herbicides activity
01/01/2003CN1097591C Process for preparing pyrimidine derivatives
12/2002
12/31/2002US6500952 Processes for preparing aminophenylsulfonylureas, and intermediates therefor
12/31/2002US6500948 Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
12/31/2002US6500835 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient